The Scientific Research team at Shoreline Biosciences employs advanced iPSC differentiation methods and genetic programming techniques to enhance the IL-15/CISH pathway, aiming to improve the metabolic fitness, persistence, and anti-cancer activity of engineered NK cells. This multidisciplinary team of scientists and engineers focuses on pioneering research and development to advance Shoreline's cell therapy technology platform.